20 May 2013
Keywords: serono, infertility, apis, made, spain, swiss, biotechnology
Article | 19 July 2004
Swiss biotechnology company Serono is set to transfer global productionof recombinant gonadotropin active pharmaceutical ingredients to Spain from Switzerland, after ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.